uniQure N.V. Ordinary Shares vs Tripadvisor Inc Common Stock — how do they compare? uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B), while Tripadvisor Inc Common Stock trades at $8.93 (market cap $1.02B). The key difference: uniQure N.V. Ordinary Shares is the larger of the two by market cap, and uniQure N.V. Ordinary Shares is more actively traded (2,488,780 versus 1,973,736). Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Tripadvisor Inc Common Stock for 58 Days on average.
| QURE | TRIP | |
|---|---|---|
Market Cap | $1.48B | $1.02B |
Volume | 2,488,780 | 1,973,736 |
Sector | Health | Consumer Cyclical |
52-Week High | $70.59 | $16.72 |
52-Week Low | $9.03 | $8.04 |
Typical Hold Time | 0 Days | 58 Days |
Enterprise Value | $728.62M | $1.08B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TripAdvisor (TRIP) trades at $8.93, up 2.41% today but near its 52-week low of $8.27. The stock shows neutral technical signals with bearish moving averages. Fundamentally, revenue grew to $1.89B in 2025 with a net income margin of 2.11%, though recent quarters show earnings misses. The P/E ratio of 218.5 reflects high valuation relative to earnings, while P/S of 0.57 suggests reasonable sales valuation. Analyst sentiment is mixed with 62.5% hold ratings.
The outlook remains cautious due to competitive pressures from AI travel tools and uneven demand. Upside exists if Viator performance improves and TheFork sale completes, but risks include persistent earnings volatility and market share erosion. The consensus price target of $13.58 offers 52% potential upside from current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →